封面
市場調查報告書
商品編碼
1698158

乳糖不耐症市場-全球產業規模、佔有率、趨勢、機會與預測,按類型、診斷、地區和競爭細分,2020-2030 年

Lactose Intolerance Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Type, By Diagnosis, By Region & Competition, 2020-2030F

出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024 年全球乳糖不耐症市場價值為 209 億美元,預計在預測期內將呈現令人印象深刻的成長,到 2030 年的複合年成長率為 6.70%。近年來,全球乳糖不耐症市場經歷了顯著的成長和演變,這得益於全球乳糖不耐症盛行率的上升以及消費者對此病症的認知的提高。乳糖不耐症是一種消化系統疾病,其特徵是身體無法消化乳糖(乳製品中的糖),導致腹痛、腹瀉和腹脹等症狀。

市場概覽
預測期 2026-2030
2024年市場規模 209億美元
2030年市場規模 309.1億美元
2025-2030 年複合年成長率 6.70%
成長最快的領域 原發性乳糖不耐症
最大的市場 北美洲

因此,對無乳糖和無乳製品(包括牛奶替代品、優格和起司替代品)的需求不斷成長,推動了乳糖不耐症市場的發展。該市場的主要促進因素之一是乳糖不耐症的盛行率不斷上升,雖然各地區情況不同,但估計會影響全球相當一部分人口。遺傳、種族和飲食習慣等因素導致了不同的盛行率。因此,人們越來越需要透過診斷測試來準確識別乳糖不耐症,同時對乳糖酶補充劑的需求也激增,這有助於乳糖不耐症患者更舒適地消化乳製品。除了乳糖不耐症盛行率不斷上升之外,飲食偏好的改變以及素食主義和植物性飲食趨勢的日益成長,進一步刺激了對無乳糖替代品的需求。這促使食品和飲料製造商投資研發,創造適合乳糖不耐症患者的創新乳製品替代品,進而擴大乳糖不耐症市場。此外,人們對乳糖不耐症的認知和教育不斷提高,鼓勵人們尋找合適的飲食選擇,導致無乳糖產品的消費量激增。因此,乳糖不耐症市場見證了老牌企業和新興公司在產品開發、行銷和分銷方面的大量投資。

關鍵市場促進因素

乳糖不耐症盛行率上升

主要市場挑戰

診斷和認知有限

主要市場趨勢

植物性飲食和純素食主義

目錄

第 1 章:產品概述

第2章:研究方法

第3章:執行摘要

第4章:顧客之聲

第5章:乳糖不耐症市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 依類型(原發性、繼發性、先天性、發育性)
    • 透過診斷(氫呼氣試驗、血糖試驗、糞便酸度試驗)
    • 按地區
    • 按公司分類(2024)
  • 市場地圖

第6章:北美乳糖不耐症市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美:國家分析
    • 加拿大
    • 墨西哥

第7章:歐洲乳糖不耐症市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲:國家分析
    • 英國
    • 義大利
    • 法國
    • 西班牙

第8章:亞太乳糖不耐症市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 亞太地區:國家分析
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章:南美乳糖不耐症市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲:國家分析
    • 阿根廷
    • 哥倫比亞

第10章:中東與非洲乳糖不耐症市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA:國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 11 章:市場動態

  • 驅動程式
  • 挑戰

第 12 章:市場趨勢與發展

  • 最新動態
  • 產品發布
  • 併購

第 13 章:全球乳糖不耐症市場:SWOT 分析

第 14 章:競爭格局

  • Kshipra Biotech Private Limited
  • EMD Serono
  • Intoleran
  • MACLEODS
  • Merck KGaA
  • DSM
  • Johnson & Johnson Services, Inc
  • NOW Foods
  • Procter & Gamble
  • Chr. Hansen Holding A/S
  • Biofermen Private Limited

第 15 章:策略建議

第16章調查會社について,免責事項

簡介目錄
Product Code: 17545

Global Lactose Intolerance Market was valued at USD 20.90 Billion in 2024 and is anticipated to project impressive growth in the forecast period with a CAGR of 6.70% through 2030. The global lactose intolerance market has witnessed significant growth and evolution in recent years, driven by a rising prevalence of lactose intolerance worldwide and an increasing awareness of this condition among consumers. Lactose intolerance is a digestive disorder characterized by the body's inability to digest lactose, a sugar found in dairy products, leading to symptoms such as abdominal pain, diarrhea, and bloating.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 20.90 Billion
Market Size 2030USD 30.91 Billion
CAGR 2025-20306.70%
Fastest Growing SegmentPrimary Lactose Intolerance
Largest MarketNorth America

As a result, there has been a growing demand for lactose-free and dairy-free products, including milk alternatives, yogurt, and cheese substitutes, which has propelled the lactose intolerance market forward. One of the key drivers of this market is the increasing prevalence of lactose intolerance, which varies by region but is estimated to affect a significant portion of the global population. Factors such as genetics, ethnicity, and dietary habits contribute to the varying prevalence rates. Consequently, there is a growing need for diagnostic tests to accurately identify lactose intolerance, as well as a surge in demand for lactase supplements, which help individuals with lactose intolerance digest dairy products more comfortably. In addition to the rising prevalence of lactose intolerance, changing dietary preferences, and the growing trend of veganism and plant-based diets, have further fueled the demand for lactose-free alternatives. This has prompted food and beverage manufacturers to invest in research and development to create innovative dairy substitutes that cater to lactose-intolerant individuals, thereby expanding the lactose intolerance market. Furthermore, increased awareness and education regarding lactose intolerance have encouraged individuals to seek out suitable dietary options, leading to a surge in the consumption of lactose-free products. Consequently, the lactose intolerance market has witnessed substantial investments in product development, marketing, and distribution by both established players and emerging companies.

Key Market Drivers

Rising Prevalence of Lactose Intolerance

The rising prevalence of lactose intolerance has emerged as a significant driver behind the growth of the global lactose intolerance market. Lactose intolerance, a condition impairing the body's ability to digest lactose, affects approximately 65-70% of the global population, presenting a significant market consideration for the dairy and alternative food industries. Prevalence rates vary notably across demographics, with higher incidence observed among Asian, African, and Hispanic populations, underscoring the demand for lactose-free and dairy substitute products in these key consumer segments. Lactose intolerance is no longer a niche concern; instead, it has become a prevalent digestive disorder affecting millions of individuals worldwide. The condition's prevalence varies by region and ethnicity, but it is estimated that a substantial portion of the global population is lactose intolerant. Factors such as genetics, age, and dietary habits contribute to the development of lactose intolerance.

Key Market Challenges

Limited Diagnosis and Awareness

Lactose intolerance, a common digestive disorder affecting millions worldwide, is a condition characterized by the body's inability to properly digest lactose, a sugar found in dairy products. While it has gained recognition in recent years, limited diagnosis and awareness remain significant hurdles hindering the growth of the global lactose intolerance market.

One of the primary challenges facing the lactose intolerance market is the underdiagnosis of this condition. Many individuals who experience symptoms such as abdominal pain, bloating, diarrhea, and gas after consuming dairy products may not recognize these signs as indicators of lactose intolerance. Instead, they may attribute these symptoms to other factors, leading to a delay in diagnosis and treatment.

Key Market Trends

Plant-Based Diets and Veganism

Plant-based diets and veganism have emerged as significant drivers behind the growth of the global lactose intolerance market. These dietary trends, characterized by the avoidance of animal-derived products, including dairy, have created a substantial demand for lactose-free alternatives, which in turn have boosted the lactose intolerance market. Individuals adopting plant-based diets and embracing veganism often seek alternatives to traditional dairy products as they align with their ethical, environmental, and health-conscious beliefs. This shift in dietary preferences has led to a surge in the consumption of plant-based milk alternatives such as almond milk, soy milk, oat milk, and coconut milk, all of which are naturally devoid of lactose.

Moreover, veganism and plant-based diets have contributed to the expansion and diversification of the lactose-free product market. Manufacturers have responded to this trend by introducing a wide array of dairy-free options that cater not only to lactose-intolerant individuals but also to vegans and individuals looking to reduce their dairy consumption.

Key Market Players

  • Kshipra Biotech Private Limited
  • EMD Serono
  • Intoleran
  • MACLEODS
  • Merck KGaA
  • DSM
  • Johnson & Johnson Services, Inc
  • NOW Foods
  • Procter & Gamble
  • Chr. Hansen Holding A/S
  • Biofermen Private Limited

Report Scope:

In this report, the Global Lactose Intolerance Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Lactose Intolerance Market, By Type:

  • Primary
  • Secondary
  • Congenital
  • Developmental

Lactose Intolerance Market, By Diagnosis:

  • Hydrogen breath test
  • Glucose blood test
  • Stool acidity test

Lactose Intolerance Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Lactose Intolerance Market.

Available Customizations:

Global Lactose Intolerance Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Lactose Intolerance Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Primary, Secondary, Congenital, Developmental)
    • 5.2.2. By Diagnosis (Hydrogen breath test, Glucose blood test, Stool acidity test)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Market Map

6. North America Lactose Intolerance Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Diagnosis
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Lactose Intolerance Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Diagnosis
    • 6.3.2. Canada Lactose Intolerance Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Diagnosis
    • 6.3.3. Mexico Lactose Intolerance Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Diagnosis

7. Europe Lactose Intolerance Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Diagnosis
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Lactose Intolerance Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Diagnosis
    • 7.3.2. United Kingdom Lactose Intolerance Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Diagnosis
    • 7.3.3. Italy Lactose Intolerance Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Diagnosis
    • 7.3.4. France Lactose Intolerance Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Diagnosis
    • 7.3.5. Spain Lactose Intolerance Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Diagnosis

8. Asia-Pacific Lactose Intolerance Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Diagnosis
    • 8.2.3. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Lactose Intolerance Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Diagnosis
    • 8.3.2. India Lactose Intolerance Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Diagnosis
    • 8.3.3. Japan Lactose Intolerance Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Diagnosis
    • 8.3.4. South Korea Lactose Intolerance Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Diagnosis
    • 8.3.5. Australia Lactose Intolerance Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Diagnosis

9. South America Lactose Intolerance Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Diagnosis
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Lactose Intolerance Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Diagnosis
    • 9.3.2. Argentina Lactose Intolerance Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Diagnosis
    • 9.3.3. Colombia Lactose Intolerance Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Diagnosis

10. Middle East and Africa Lactose Intolerance Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Diagnosis
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Lactose Intolerance Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product Type
        • 10.3.1.2.2. By Application
    • 10.3.2. Saudi Arabia Lactose Intolerance Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Diagnosis
    • 10.3.3. UAE Lactose Intolerance Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Diagnosis

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Product Launches
  • 12.3. Mergers & Acquisitions

13. Global Lactose Intolerance Market: SWOT Analysis

14. Competitive Landscape

  • 14.1. Kshipra Biotech Private Limited
    • 14.1.1. Business Overview
    • 14.1.2. Product & Service Offerings
    • 14.1.3. Recent Developments
    • 14.1.4. Financials (If Listed)
    • 14.1.5. Key Personnel
    • 14.1.6. SWOT Analysis
  • 14.2. EMD Serono
  • 14.3. Intoleran
  • 14.4. MACLEODS
  • 14.5. Merck KGaA
  • 14.6. DSM
  • 14.7. Johnson & Johnson Services, Inc
  • 14.8. NOW Foods
  • 14.9. Procter & Gamble
  • 14.10.Chr. Hansen Holding A/S
  • 14.11.Biofermen Private Limited

15. Strategic Recommendations

16. About Us & Disclaimer